DNA polymorphisms and mutations of the tumor necrosis factor-α (TNF- α) promoter in langerhans cell histiocytosis (LCH)

Journal of Interferon and Cytokine Research

Volumn 17, Issue 10, 1997, Pages 631-635

  Wu, Wen Shu ^a   McClain, Kenneth L ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; DENDRITE; DNA DETERMINATION; DNA FINGERPRINTING; DNA POLYMORPHISM; DNA SEQUENCE; GENE EXPRESSION; GENE MUTATION; HISTIOCYTOSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE;

EID: 0030868696     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1997.17.631     Document Type: Article

References (25)

1. McCLAIN, K.L., HUTTER, J.J., and CASSADY, J.R. (1994). Langerhans cell histiocytosis. In: Radiation Therapy in Pediatric Oncology. J.R. Cassady (ed.) New York: Springer-Verlag, pp. 337-349.
2. FAVARA, B.E. (1981). The pathology of "histiocytosis." Am. J. Pediatr. Hematol. Oncol. 3, 45-56.
3. McCLAIN, K., JIN, H., GRESIK, V., and FAVARA, B. (1994). Langerhans cell histocytosis: lack of a viral etiology. Am. J. Hematol. 47, 16-20.
4. LEAHY, M.A., KREJCI, S.M., FRIEDNASH, M., STOCKERT, S.S., WILSON, H., HUFF, W.J.C., WESTON, W.L., and BRICE, S.L. (1993). Human herpesvirus 6 is present in lesions of Langerhans cell histiocytosis. J. Invest. Dermatol. 101, 642-645.
5. WILLMAN, C.L., BUSQUE, L., GRIFFITH, B.B., FAVARA, B.E., McCLAIN, K.L., DUNCAN, M.H., and GILLILAND, G. (1994). Langerhans' cell histiocytosis (histiocytosis X) - a clonal proliferate disease. N. Engl. J. Med. 331, 154-160.
6. KANNORAKIS, G., and ABBAS, A. (1994). The role of cytokines in the pathogenesis of Langerhans cell histiocytosis. Br J. Cancer 70 (Suppl. XXIII), S37-S40.
7. CAUX, C., DEAUTTER-DAMBUYANT, C., SCHMITT, D., and BANCHEREAU, J. (1992). GM-CSF and TNFa co-operate in the generation of dendritic Langerhans cells. Nature 360, 258-261.
8. GOLDFIELD, A.E., McCAFFREY, P.G., STROMINGER, J.L., and RAO, A. (1993). Identification of a novel cyclosporin-sensitive element in the human tumor necrosis factor α gene promoter. J. Exp. Med. 178, 1365-1379.
9. MAHMOUD, H., WANG, W., and MURPHY, S.B. (1991). Cyclosporine therapy for advanced Langerhans cell histiocytosis. Blood 77, 721-725.
10. TAKASHIBA, S., SHAPIRA, L., AMAR, S., and VAN DYKE, T.E. (1993). Cloning and characterization of human TNFα promoter region. Gene 131, 307-308.
11. COLLART, M.A., BAEUERLE, P., and VASSALLI, P. (1990). Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four κ-like motifs and of constitutive and inducible forms of NK-κB. Mol. Cell Biol. 10, 1498-1506.
12. FAISST, S., and MEYER, S. (1992). Compilation of vertebrate-encoded transcription factors. Nucleic Acids Res. 20, 3-26.
13. FONG, C-L. W., SIDDQUI, A.H., and MARK, D.F. (1994). Identification and characterization of a novel repressor site in the human tumor necrosis factor α gene. Nucleic Acids. Res. 22, 1108-1114.
14. BRINKMAN, B.M.N., GIPHART, M.J., VERHOEF, A., KAIJZEL, E.L., NAIPAL, A.M., DAHA, M.R., BREEDVELD, F.C., and VERMEIJ, C.L. (1994). Tumor necrosis factor α-308 gene variants in relation to major histocompatibility complex alleles and Felty's syndrome. Human Immunol. 41, 259-266.
15. WILSON, A.G., DE VRIES, N., POCIOT, F., DI GIOVINE, F.S., VAN DER PUTTE, L.B.A., and DUFF, G.W. (1995). An allelic polymorphism within the human tumor necrosis factor a promoter region is strongly associated with HLA A1, B8, and DR3 Alleles. J. Exp. Med. 177, 557-560.
16. BENDTZEN, K., MORLING, N., FOMSGAARD, A., SVENSON, M., JAKOBSEN, B., ODUM, N., and SVEJGAARD, A. (1988). Association between HLA-DR2 and production of tumour necrosis factor α and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scand. J. Immunol. 28, 599-606.
17. JACOB, C.O., FRONEK, Z., LEWIS, G.D., KOO, M., HANSEN, J.A., and McDEVITT, H.O. (1990). Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor α: relevance to genetic predisposition to systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 87, 1233-1237.
18. LIU, Q., and SOMMER, S.S. (1994). Parameter affecting the sensitivity of dideoxy fingerprinting and SSCP. PCR Methods Appl. 4, 97-108.
19. MANIATIS, T., FRITSCH, E.F., and SAMBROOK, J. (1982). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
20. SCHWARTZ, B.D. (1992). The major histocompatibility complex and disease susceptibility. In: J.B. Wyngaarden, L.H. Smith, Jr., and J.C. Bennett (eds.) Cecil Textbook of Medicine. Philadelphia: Saunders, pp. 1470-1479.
21. 2 shows stable interindividual differences. Scand. J. Immunol. 27, 705-716.
22. McGUIRE, W., HILL, A.V.S., ALLSOPP, C.E.M., GREENWOOD, B.M., and KWIATKOWSKI, D. (1994). Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 371, 508-511.
23. STUBER, F., UDALOVA, I.A., BOOK, M., DRUTSKAYA, L.N., KUPRASH, D.V., TURETSKAYA, R.L., SCHADE, F.U., and NEDOSPASOV, S.A. (1996). 308 Tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J. Inflam. 46, 42-50.
24. DEWET, J.R., WOOD, K.V., DELUCA, M., HELINSKI, D.R., and SUBRAMANI, S. (1987). Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol. 7, 725-737.
25. JONGENEEL, C.V., and BEUTLER, B. (1996). Genetic polymorphism in the human TNF regions: correlation or causation? J. Inflam. 46, iii-vi.